The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Osimertinib as neoadjuvant treatment for resectable stage II-IIIB EGFR mutant lung adenocarcinoma (NEOS).
 
Chao Lyu
No Relationships to Disclose
 
Wentao Fang
No Relationships to Disclose
 
Haitao Ma
No Relationships to Disclose
 
Jia Wang
No Relationships to Disclose
 
Wenjie Jiao
No Relationships to Disclose
 
Rui Wang
No Relationships to Disclose
 
Nan Wu
No Relationships to Disclose
 
Shi-Dong Xu
No Relationships to Disclose
 
Yue Yang
No Relationships to Disclose